The first drug-related death associated with xylazine use in the UK and Europe.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Abstract
On November 8th, 2022, the United States Food and Drug Administration (FDA) issued a statement alerting healthcare professionals to the increasing prevalence of xylazine in illicit drug overdoses in the country. Xylazine is a veterinary medicine with sedative, analgesic and muscle relaxant properties that is used as a heroin/fentanyl adulterant on the illicit drug market in North America. Here we report the first drug-related death associated with xylazine in the United Kingdom.Citation
Rock KL, Lawson AJ, Duffy J, Mellor A, Treble R, Copeland CS. The first drug-related death associated with xylazine use in the UK and Europe. J Forensic Leg Med. 2023 Jul;97:102542. doi: 10.1016/j.jflm.2023.102542. Epub 2023 May 22. PMID: 37236142.Type
ArticleAdditional Links
http://www.sciencedirect.com/science/journal/1752928XPMID
37236142Publisher
Elsevierae974a485f413a2113503eed53cd6c53
10.1016/j.jflm.2023.102542